Luis A. Quinones-S
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.
Journal: Pharmacogenomics
Published: August 11, 2026
Importance of and Strategies for Implementing DPYD Testing to Prevent Severe Fluoropyrimidine Chemotherapy Toxicity in Health Care Systems.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 28, 2026
Association Between CYP2C9 and CYP2C19 Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 11, 2025
Addressing genetic diversity and health inequities: RELIVAF's proposal for Latin American pharmacogenomic guidelines.
Journal: Frontiers in pharmacology
Published: October 09, 2025
Genotyping of the DPYD Gene: An Ethical and Legal Obligation for the Protection of the Oncology Patient
Journal: Revista medica de Chile
Published: September 29, 2025
Cost-effectiveness of genotype-guided acenocoumarol therapy in atrial fibrillation: a pharmacogenomic simulation study in the chilean population.
Journal: The pharmacogenomics journal
Published: August 19, 2025
Editorial: Head and neck squamous cell carcinoma: navigating the dawn of personalized medicine.
Journal: Frontiers in oncology
Published: August 12, 2025
Editorial: Editor's feature: negative findings in pharmacogenetics and pharmacogenomics volume II.
Journal: Frontiers in pharmacology
Published: July 03, 2025
A Successful Experience of Individualized Vancomycin Dosing in Critically Ill Patients by Using a Loading Dose and Maintenance Dose.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 19, 2025
Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer.
Journal: Frontiers in oncology
Published: March 07, 2025
Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial.
Journal: Lancet regional health. Americas
Published: January 15, 2025
Last Updated: 09/26/2026